Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838082 · ClinicalTrials.gov registry record · NA
Optimized Sleep After Brain Injury: Sleep Hygiene Intervention After Traumatic Brain Injury
A NA study, sponsored by Craig Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02838082: Completed NA study, sponsored by Craig Hospital.
NCT02838082 is a NA study that has completed, run by Craig Hospital. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02838082, a NA study, has completed, sponsored by Craig Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
OSABI is a pilot study of a sleep hygiene protocol for sleep disruptions associated with TBI during inpatient rehabilitation. Twenty participants will be allocated (by minimization) either into a standard of care protocol or a sleep hygiene protocol for 4 weeks. Sleep efficiency (via actigraphy), post traumatic amnesia (OLOG), agitation (Agitated Behavior Scale) and cognitive function (Confusion Assessment Protocol) will be monitored during the trial period to examine relationships among them.
Primary Outcome
Sleep efficiency via actigraphy is recorded nightly for 4 weeks
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Sleep Hygiene Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02838082 record still lists
NCT02838082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02838082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02838082 about?
NCT02838082 is a clinical study titled "Optimized Sleep After Brain Injury: Sleep Hygiene Intervention After Traumatic Brain Injury". OSABI is a pilot study of a sleep hygiene protocol for sleep disruptions associated with TBI during inpatient rehabilitation. Twenty participants will be allocated (by minimization) either into a standard of care protocol or a sleep hygiene protocol for 4 weeks. Sleep efficiency (via actigraphy), po...
What is the current status of trial NCT02838082?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-08. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02838082?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Sleep Hygiene Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT02838082?
This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02838082's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia